{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006915",
      "entity_text" : "apoptosis",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF04886",
      "entity_text" : "Pt",
      "entity_type" : "family"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "33.5 +/- 4.6%, 49.6 +/- 3.7%, 67.2 +/- 2.6% and 79.8 +/- 3.4%, respectively, when the cells were incubated with cisplatin, Pt (IV) NPs, Pt (IV) NPs+ US, Pt (IV) NP-cRGD and Pt (IV) NP-cRGD+ US, indicating that Pt (IV) NP-cRGD with US significantly enhanced the apoptosis in SKOV3 cells.",
  "reading_complete" : "2020-08-02T17:58:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T17:50:32Z",
  "trigger" : "enhanced",
  "evidence" : [ "Pt(IV) NP-cRGD with US significantly enhanced the apoptosis" ],
  "pmc_id" : "6401401",
  "score" : 0
}